Concepedia

Joanna Schmidt

JS

Statistics

Publications

3

Citations

804

H-Index

3

Active since

2015

Affiliations

Ionis Pharmaceuticals (United States)(Current)

Memorial Sloan Kettering Cancer Center

AstraZeneca (South Korea)

AstraZeneca (United States)

The University of Texas MD Anderson Cancer Center

Joanna Schmidt is an author at Ionis Pharmaceuticals (United States) specializing in molecular oncology, oncology, and jak-stat pathway antagonism.

Publications per year

2015–2019

3

Publications

3

AZD9150, a next-generation antisense oligonucleotide inhibitor of <i>STAT3</i> with early evidence of clinical activity in lymphoma and lung cancer

David S. Hong, Razelle Kurzrock, Youngsoo Kim et al. · Science Translational Medicine · 2015 · 440 citations · Full text

, , +8

STAT3 antisense oligonucleotide AZD9150 in a subset of patients with heavily pretreated lymphoma: results of a phase 1b trial

Matthew J. Reilley, Patricia McCoon, Carl Cook et al. · Journal for ImmunoTherapy of Cancer · 2018 · 288 citations · Full text

, , +13

Enhanced Potency of GalNAc-Conjugated Antisense Oligonucleotides in Hepatocellular Cancer Models

Youngsoo Kim, Minji Jo, Joanna Schmidt et al. · Molecular Therapy · 2019 · 76 citations · Full text

, , +17

1–3 of 3